Moderna Inc at Piper Jaffray Healthcare Conference Transcript
Hi, my name is Ted Tenthoff. I'm a senior biotech analyst at Piper Jaffray. And before I begin, I'm required to point out certain disclosures regarding the relationship -- sorry, getting a little feedback -- with Piper -- there we go. That's better. And Moderna that approach both at the back of the room and also at the registration desk.
As you may have heard, Moderna is the leading developer of messenger RNA or mRNA therapy. The mRNA is the drug, and it actually induces endogenous expression of therapeutic proteins to treat different diseases. Moderna has a rich pipeline, so I want to jump right in to cover as much of the story as possible.
I'm pleased to introduce my good friend, CFO, Lorence Kim. Lorence, last year at the conference, you guys were on the road doing the IPO. So you weren't able to be here. So this is your first time. I'm happy to have you.
Thank you for having me. I'm so
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |